UBS Maintains Houlihan Lokey(HLI.US) With Buy Rating, Cuts Target Price to $195
Wells Fargo Maintains Houlihan Lokey(HLI.US) With Buy Rating, Cuts Target Price to $170
Houlihan Lokey Is Maintained at Overweight by Wells Fargo
Morgan Stanley Maintains Houlihan Lokey(HLI.US) With Buy Rating, Cuts Target Price to $156
Morgan Stanley Maintains Overweight on Houlihan Lokey, Lowers Price Target to $156
Houlihan Lokey Analyst Ratings
Houlihan Lokey Raised to Overweight From Underweight by Morgan Stanley
Morgan Stanley Upgrades Houlihan Lokey(HLI.US) to Buy Rating, Raises Target Price to $190
Wells Fargo Upgrades Houlihan Lokey(HLI.US) to Buy Rating, Cuts Target Price to $179
Houlihan Lokey Analyst Ratings
Wells Fargo Upgrades Houlihan Lokey to Overweight From Underweight, Adjusts Price Target to $179 From $180
A Quick Look at Today's Ratings for Houlihan Lokey(HLI.US), With a Forecast Between $180 to $230
Houlihan Lokey Is Maintained at Underweight by Wells Fargo
Houlihan Lokey Is Maintained at Buy by UBS
Houlihan Lokey Price Target Raised to $230.00/Share From $229.00 by UBS
Houlihan Lokey Analyst Ratings
Cautious Outlook on Houlihan Lokey: Sell Rating Despite Strong Earnings and Revenue Growth
Morgan Stanley Lifts Price Target on Houlihan Lokey to $201 From $200, Keeps Underweight Rating
KBW Maintains Houlihan Lokey(HLI.US) With Hold Rating, Raises Target Price to $192
JMP Securities Maintains Houlihan Lokey(HLI.US) With Hold Rating